Trading analysis backed by real performance data

DXY hit 99.50 after Trump threats. The rally is less about safe-haven flows and more about rate differentials and liquidity. PCE data is the next test.

TGA approval unlocks Australian commercialization for OncoSil's pancreatic cancer device. Manufacturing scale-up and cash burn remain key risks for ASX:OSL. Watch for dose sales growth.

Taiwan passed Canada as 6th-largest market; South Korea overtook the UK for 8th. The AI hardware trade drives the rally, but concentration risk is rising.

Agoda survey: 63% of Malaysian travelers open to lesser-known destinations in 2026. 47% expect mostly domestic trips. Relaxation leads at 69%. Framework for tourism stock allocation.

Over 3 million households trust GROWNSY. Its 2026 ABC Kids Expo debut of four products drew buyers from Walmart and Target. The key question: will these innovations convert to shelf placement?

A bullish Seeking Alpha thesis on Halozyme (HALO) highlights rapidly growing royalty income. The top three partners concentrate risk. October earnings will test the story.

GBP/USD drops below 1.3100 as Middle East escalation drives safe-haven dollar demand. The risk-off rotation exposes sterling's current account deficit. Key support at 1.3050.

Around 10 foreign firms filed for Hong Kong listings this year, from biotech to blockchain. Blockdaemon's filing could set precedent for crypto infrastructure IPOs in Asia.

10-year yield breakout above 4.48 targets 4.75, driven by failed Iran diplomacy, oil at $110, and a 60% Fed hike probability. Watch the path to 5%.

Scott Bessent's public criticism gives BOJ cover for a June rate hike. The yen's rally still depends on a narrowing yield gap that requires Fed cooperation.